TCRX TScan Therapeutics: Company Short-Term Debts

Symbol and logo of brand TScan (TCRX)

TScan Therapeutics (TCRX) faces intense pressure from global tech giants in the T-cell therapy sector, yet the flexibility of its tumor-fighting platform offsets the risks of a narrow portfolio. Monitoring current debt allows for a comparison of these factors, where the 0.01 level reflects the current magnitude of liabilities. Business stability is ensured by complete independence from economic cycles and a reliable liquidity reserve.

TCRX tscan.com Company Short-Term Loans and Borrowings (07/04/2022 - 10/29/2026)

TCRX (TScan Therapeutics Inc): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price TScan|TCRX - Consensus Target
- company stock capitalization data:
Market Capitalization TScan Therapeutics, Inc.|TCRX - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share TScan Therapeutics|TCRX - Accounting Value of Company|Market Cap to Net Assets Ratio tscan.com|TCRX - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital TScan Therapeutics|TCRX - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio TScan|TCRX - Company Aggregate Debts|Debt to Book Capitalization Ratio TScan Therapeutics, Inc.|TCRX - Company Long-Term Loans and Borrowings|Company Short-Term Debts TScan Therapeutics|Quick Liquidity Indicator tscan.com
- earnings and multiples data:
TCRX - Profit After Payment of Taxes
Analysis of all company metrics:TCRX - tscan.com
Manufactured products of TScan Therapeutics

The scale of cell therapy development at TScan Therapeutics (TCRX) requires precise control of obligations maturing within one year, reflecting the mathematical volume of current debt payments. By analyzing the short-term debt trend, investors assess the biotech's liquidity, which, given the non-cyclical nature of the business and macro-stability, confirms the asset's financial reliability regardless of economic cycle phases.

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|candeltx.com (CADL) - Company Short-Term Debt|Accuray Inc - Company Short-Term Loans and Borrowings|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Short-Term Debt Actuate Therapeutics Inc ACTU|Company Current Liabilities CTOR (Citius Oncology, Inc.)|Amount of Current Liabilities HURA|Company Short-Term Debt Protara Therapeutics, Inc. TARA|Short-Term Debt Volume Fate Therapeutics Inc (FATE)|Aadi Bio - Company Short-Term Debts|Champions Oncology (CSBR) - Company Current Liabilities|XBIT: Company Short-Term Debts|CEL-SCI (CVM) - Company Short-Term Debts|Company Short-Term Debt OS Therapies|Company Short-Term Indebtedness RADX (Radiopharm Theranostics Ltd)|Company Current Liabilities ARTV (Artiva Biotherapeutics, Inc.)|ANL (adlainortye.com) - Company Short-Term Loans and Borrowings|Veru Inc. - Company Current Liabilities|Amount of Current Liabilities TPST (tempesttx.com)|Xilio - Company Short-Term Debts|Company Short-Term Loans and Borrowings RENB (Renovaro Inc.)|MURA: Company Short-Term Debts|Short-Term Debt Kairos Pharma (KAPA)|Company Short-Term Debt OnKure Therapeutics, Inc.|GDTC: Company Short-Term Loans and Borrowings|Company Short-Term Debts CRIS|Company Short-Term Debts apollomicsinc.com (APLM)|Company Short-Term Debt Tharimmune Corp THAR|ADVB (Advanced Biomed Inc.) - Current Liabilities|Genprex, Inc. - Company Short-Term Debts|Short-Term Debt Calidi Biotherapeutics|SBFM (Sunshine Biopharma) - Company Current Liabilities|Xenetic Biosciences, Inc. (XBIO) - Company Short-Term Debts|Company Current Liabilities SLRX|PPBT (Kitov Pharma) - Amount of Current Liabilities|Company Short-Term Debts AONC|Short-Term Debt Volume beigene.com|Company Short-Term Debts CKPT (Checkpoint Therapeutics, Inc.)|ELEV - Company Current Liabilities|ICAD - Company Short-Term Debt|Short-Term Debt Volume Ikena Oncology, Inc. IKNA|NTBL (Notable Labs, Ltd.) - Company Current Liabilities|VIRX: Amount of Current Liabilities|MOR (MorphoSys) - Company Short-Term Debts|Company Current Liabilities NAYA Biosciences Inc (NAYA)|Company Short-Term Debt Ascentage Pharma Group Ltd (AAPGV)